R E Ferner

8.6k total citations
223 papers, 4.9k citations indexed

About

R E Ferner is a scholar working on Toxicology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, R E Ferner has authored 223 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Toxicology, 49 papers in Pediatrics, Perinatology and Child Health and 32 papers in Pharmacology. Recurrent topics in R E Ferner's work include Pharmacovigilance and Adverse Drug Reactions (48 papers), Pharmaceutical studies and practices (34 papers) and Pharmaceutical Practices and Patient Outcomes (27 papers). R E Ferner is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (48 papers), Pharmaceutical studies and practices (34 papers) and Pharmaceutical Practices and Patient Outcomes (27 papers). R E Ferner collaborates with scholars based in United Kingdom, United States and Australia. R E Ferner's co-authors include Jeffrey K Aronson, Sarah McDowell, Jamie J. Coleman, Anthony Cox, Sally Bradberry, J. Mark Wilkinson, H. A. W. Neil, D. Nicholas Bateman, J K Aronson and M. D. Rawlins and has published in prestigious journals such as The Lancet, PLoS ONE and Neurology.

In The Last Decade

R E Ferner

213 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R E Ferner United Kingdom	36	844	724	624	616	574	223	4.9k
Martin Schulz Germany	31	957 1.1×	466 0.6×	159 0.3×	538 0.9×	492 0.9×	155	4.1k
Peter A. G. M. De Smet Netherlands	37	1.2k 1.4×	236 0.3×	323 0.5×	503 0.8×	230 0.4×	166	4.7k
Anton Pottegård Denmark	46	1.0k 1.2×	323 0.4×	170 0.3×	991 1.6×	1.3k 2.2×	385	10.0k
J. R. B. J. Brouwers Netherlands	39	1.0k 1.2×	164 0.2×	476 0.8×	527 0.9×	723 1.3×	196	4.5k
David Williams Ireland	40	537 0.6×	191 0.3×	545 0.9×	224 0.4×	697 1.2×	245	5.5k
Bernard Bégaud France	34	840 1.0×	565 0.8×	87 0.1×	448 0.7×	1.1k 1.9×	179	6.8k
Simon Maxwell United Kingdom	44	852 1.0×	114 0.2×	453 0.7×	336 0.5×	604 1.1×	156	7.0k
Gianluca Trifirò Italy	46	888 1.1×	1.4k 1.9×	95 0.2×	986 1.6×	524 0.9×	270	7.0k
Ulf Bergman Sweden	43	913 1.1×	541 0.7×	89 0.1×	1.0k 1.7×	490 0.9×	178	6.6k
Elaine M. Hylek United States	79	535 0.6×	450 0.6×	421 0.7×	241 0.4×	2.7k 4.7×	252	31.2k

Countries citing papers authored by R E Ferner

Since Specialization

Citations

This map shows the geographic impact of R E Ferner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R E Ferner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R E Ferner more than expected).

Fields of papers citing papers by R E Ferner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R E Ferner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R E Ferner. The network helps show where R E Ferner may publish in the future.

Co-authorship network of co-authors of R E Ferner

This figure shows the co-authorship network connecting the top 25 collaborators of R E Ferner. A scholar is included among the top collaborators of R E Ferner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R E Ferner. R E Ferner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ferner, R E & Jeffrey K Aronson. (2024). Competing Benefits and Competing Hazards: The Benefit to Harm Balance in Individual Patients in Rational Therapeutics. Drug Safety. 47(8). 721–731. 2 indexed citations

Aronson, Jeffrey K, Carl Heneghan, & R E Ferner. (2023). Drug shortages. Part 1. Definitions and harms. British Journal of Clinical Pharmacology. 89(10). 2950–2956. 8 indexed citations

Aronson, Jeffrey K, Carl Heneghan, & R E Ferner. (2023). Drug shortages. Part 2: Trends, causes and solutions. British Journal of Clinical Pharmacology. 89(10). 2957–2963. 9 indexed citations

Chung, Jennifer, et al.. (2023). Effectiveness of biosimilar adoption within a UK tertiary hospital: 6‐year follow‐up. British Journal of Clinical Pharmacology. 89(10). 2944–2949. 1 indexed citations

Ferner, R E, et al.. (2023). Recognition of Coroners’ Concerns to Prevent Future Deaths from Medicines: A Systematic Review. Pharmaceutical Medicine. 37(5). 357–363. 2 indexed citations

Ferner, R E & Jeffrey K Aronson. (2022). Medicines legislation and regulation in the United Kingdom 1500‐2020. British Journal of Clinical Pharmacology. 89(1). 80–92. 3 indexed citations

Ferner, R E, Richard Stevens, Christopher G. Anton, & Jeffrey K Aronson. (2022). Spontaneous Reporting to Regulatory Authorities of Suspected Adverse Drug Reactions to COVID-19 Vaccines Over Time: The Effect of Publicity. Drug Safety. 45(2). 137–144. 13 indexed citations

Aronson, Jeffrey K & R E Ferner. (2020). Analysis of reports of unintended pregnancies associated with the combined use of non-enzyme-inducing antibiotics and hormonal contraceptives. BMJ evidence-based medicine. 26(3). 112–113. 9 indexed citations

Bodalia, Pritesh, et al.. (2019). A novel approach to support implementation of biosimilars within a UK tertiary hospital. British Journal of Clinical Pharmacology. 86(1). 23–28. 8 indexed citations

10.

Dimmitt, Simon B., Hans G. Stampfer, Jennifer Martin, & R E Ferner. (2019). Efficacy and toxicity of antihypertensive pharmacotherapy relative to effective dose 50. British Journal of Clinical Pharmacology. 85(10). 2218–2227. 6 indexed citations

11.

Ferner, R E & Jeffrey K Aronson. (2019). Susceptibility to adverse drug reactions. British Journal of Clinical Pharmacology. 85(10). 2205–2212. 22 indexed citations

12.

Aronson, Jeffrey K & R E Ferner. (2017). Unlicensed and off‐label uses of medicines: definitions and clarification of terminology. British Journal of Clinical Pharmacology. 83(12). 2615–2625. 58 indexed citations

13.

McDowell, Sarah, et al.. (2008). Should doctors who make clinical errors be charged with manslaughter? A survey of medical professionals and members of the public. Medicine Science and the Law. 48(4). 317–324. 4 indexed citations

14.

Ferner, R E. (2005). A fruitful idea. Journal of Postgraduate Medicine. 51(5). 4. 2 indexed citations

15.

Ferner, R E. (1998). Increase in US medication-error death (Letter comment). The Lancet. 351. 1655–1656. 1 indexed citations

16.

Ferner, R E. (1996). Doctors should decline to see them. BMJ. 313(7061). 881.3–881.3. 1 indexed citations

17.

Ferner, R E. (1996). Martindale's Extra Pharmacopoeia. BMJ. 313(7066). 1214.2–1214.2. 18 indexed citations

18.

Ferner, R E, et al.. (1990). Medical problems of adults who were sexually abused in childhood. BMJ. 300(6733). 1197.3–1197. 3 indexed citations

19.

Bassendine, Margaret F., et al.. (1983). Prospective study of post-transfusion hepatitis after cardiac surgery in a British centre.. BMJ. 287(6403). 1422–1424. 41 indexed citations

20.

Ferner, R E. (1979). Outpatient preoperative assessment: the surgeon's view.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 61(6). 477–477. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact